333 related articles for article (PubMed ID: 7783695)
1. Pathogenesis and management of hypercalciuric nephrolithiasis.
Breslau NA
Miner Electrolyte Metab; 1994; 20(6):328-39. PubMed ID: 7783695
[TBL] [Abstract][Full Text] [Related]
2. [Bone involvement in idiopathic calcium lithiasis].
Ghazali A; Bataille P; Solal MC; Marié A; Brazier M; Sebert JL; Prin L; Fournier A
Nephrologie; 1995; 16(5):351-69. PubMed ID: 7566325
[TBL] [Abstract][Full Text] [Related]
3. A cautious use of sodium cellulose phosphate in the management of calcium nephrolithiasis.
Pak CY
Invest Urol; 1981 Nov; 19(3):187-90. PubMed ID: 7298289
[TBL] [Abstract][Full Text] [Related]
4. Bone disease in idiopathic hypercalciuria.
Heilberg IP; Weisinger JR
Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):394-402. PubMed ID: 16775454
[TBL] [Abstract][Full Text] [Related]
5. [Alterations in bone mineral metabolism in patients with calcium kidney stone disease and polymorphism of vitamin D receptor. Preliminary results].
Moyano MJ; Gómez de Tejada MJ; García Lozano R; Moruno R; Ortega R; Martí V; Sánchez Palencia R; Miranda MJ; Palma A; Pérez Cano R
Nefrologia; 2007; 27(6):694-703. PubMed ID: 18336098
[TBL] [Abstract][Full Text] [Related]
6. Calciotropic hormones and nephrolithiasis.
D'Angelo A; Calò L; Cantaro S; Giannini S
Miner Electrolyte Metab; 1997; 23(3-6):269-72. PubMed ID: 9387131
[TBL] [Abstract][Full Text] [Related]
7. Association between vitamin D receptor gene polymorphisms and fasting idiopathic hypercalciuria in recurrent stone-forming patients.
Rendina D; Mossetti G; Viceconti R; Sorrentino M; Castaldo R; Manno G; Guadagno V; Strazzullo P; Nunziata V
Urology; 2004 Oct; 64(4):833-8. PubMed ID: 15491743
[TBL] [Abstract][Full Text] [Related]
8. Reduced vertebral bone density in hypercalciuric nephrolithiasis.
Pietschmann F; Breslau NA; Pak CY
J Bone Miner Res; 1992 Dec; 7(12):1383-8. PubMed ID: 1481724
[TBL] [Abstract][Full Text] [Related]
9. [Renal tubular function in children with hypercalciuria].
Kovacević L; Kovacević S; Smoljanić Z; Kostić M; Peco-Antić A; Gajić M; Kovacević M; Jovanović O
Srp Arh Celok Lek; 1998; 126(7-8):223-7. PubMed ID: 9863386
[TBL] [Abstract][Full Text] [Related]
10. Studies on intestinal calcium absorption in patients with idiopathic hypercalciuria.
Duncombe VM; Watts RW; Peters TJ
Q J Med; 1984; 53(209):69-79. PubMed ID: 6546801
[TBL] [Abstract][Full Text] [Related]
11. Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions.
Pak CY; Heller HJ; Pearle MS; Odvina CV; Poindexter JR; Peterson RD
J Urol; 2003 Feb; 169(2):465-9. PubMed ID: 12544288
[TBL] [Abstract][Full Text] [Related]
12. [Functional evaluation in patients with kidney calculi].
Stojimirović B
Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414
[TBL] [Abstract][Full Text] [Related]
13. [Determination of the degree of saturation of calcium hydrogen phosphate in the urine].
Reusz G; Szabó A; Tulassay T
Orv Hetil; 1989 Mar; 130(11):565-8. PubMed ID: 2927936
[TBL] [Abstract][Full Text] [Related]
14. Update on primary hypercalciuria from a genetic perspective.
Vezzoli G; Soldati L; Gambaro G
J Urol; 2008 May; 179(5):1676-82. PubMed ID: 18343451
[TBL] [Abstract][Full Text] [Related]
15. The relation between bone and stone formation.
Krieger NS; Bushinsky DA
Calcif Tissue Int; 2013 Oct; 93(4):374-81. PubMed ID: 23247537
[TBL] [Abstract][Full Text] [Related]
16. Nephrolithiasis.
Scheinman SJ
Semin Nephrol; 1999 Jul; 19(4):381-8. PubMed ID: 10435676
[TBL] [Abstract][Full Text] [Related]
17. Nephrocalcinosis in siblings--familial hypomagnesemia, hypercalciuria with nephrocalcinosis (FHHNC syndrome).
Prabahar MR; Manorajan R; Fernando ME; Venkatraman R; Balaraman V; Jayakumar M
J Assoc Physicians India; 2006 Jun; 54():497-500. PubMed ID: 16909703
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of fasting hypercalciuria associated with increased citraturia in the ambulatory evaluation of nephrolithiasis.
Damasio B; Massarino F; Durand F; Banchero R; Bottino P; De Franchis V; Carmignani G; Cannella G
J Nephrol; 2005; 18(3):262-6. PubMed ID: 16013013
[TBL] [Abstract][Full Text] [Related]
19. Bone mass loss in calcium stone disease: focus on hypercalciuria and metabolic factors.
Caudarella R; Vescini F; Buffa A; Sinicropi G; Rizzoli E; La Manna G; Stefoni S
J Nephrol; 2003; 16(2):260-6. PubMed ID: 12768074
[TBL] [Abstract][Full Text] [Related]
20. Resorptive and absorptive hypercalciuria. Therapy with sodium cellulose phosphate or thiazides.
Hering F; Lutzeyer W
Eur Urol; 1979; 5(1):29-31. PubMed ID: 428408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
